Literature DB >> 1916470

Viral hepatitis.

J Y Lau1, G J Alexander, A Alberti.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1916470      PMCID: PMC1405217          DOI: 10.1136/gut.32.suppl.s47

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  200 in total

1.  Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis.

Authors:  G R Reyes; M A Purdy; J P Kim; K C Luk; L M Young; K E Fry; D W Bradley
Journal:  Science       Date:  1990-03-16       Impact factor: 47.728

2.  Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.

Authors:  T Miyamura; I Saito; T Katayama; S Kikuchi; A Tateda; M Houghton; Q L Choo; G Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 3.  Changing epidemiology and clinical aspects of hepatitis A.

Authors:  A Forbes; R Williams
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

Review 4.  Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis.

Authors:  Q L Choo; A J Weiner; L R Overby; G Kuo; M Houghton; D W Bradley
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

5.  Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice.

Authors:  F V Chisari; P Filippi; A McLachlan; D R Milich; M Riggs; S Lee; R D Palmiter; C A Pinkert; R L Brinster
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

6.  Fine specificity of human antibody response to the PreS1 domain of hepatitis B virus.

Authors:  A Alberti; D Cavalletto; L Chemello; F Belussi; G Fattovich; P Pontisso; G Milanesi; A Ruol
Journal:  Hepatology       Date:  1990-08       Impact factor: 17.425

7.  A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B.

Authors:  M R Brunetto; M Stemler; F Bonino; F Schodel; F Oliveri; M Rizzetto; G Verme; H Will
Journal:  J Hepatol       Date:  1990-03       Impact factor: 25.083

8.  Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection.

Authors:  A Alberti; S Diana; G H Sculard; A L Eddleston; R Williams
Journal:  Br Med J       Date:  1978-10-14

9.  Biochemical and genetic evidence for the hepatitis B virus replication strategy.

Authors:  C Seeger; D Ganem; H E Varmus
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

10.  Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.

Authors:  W M Lee; W D Reed; C G Osman; J Vahrman; A J Zuckerman; A L Eddleston; R Williams
Journal:  Gut       Date:  1977-03       Impact factor: 23.059

View more
  3 in total

Review 1.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

2.  Hepatic expression of interferon-alpha in chronic hepatitis B virus infection.

Authors:  J W Fang; P C Wu; C L Lai; C K Lo; A Meager; J Y Lau
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

Review 3.  Cell Penetrating Peptides Used in Delivery of Therapeutic Oligonucleotides Targeting Hepatitis B Virus.

Authors:  Bénédicte Ndeboko; Serge Thierry Omouessi; Brice Ongali; Augustin Mouinga-Ondémé
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.